Lymphangioleiomyomatosis screening in women with tuberous sclerosis

Chest

Volumn 144, Issue 2, 2013, Pages 578-585

  Cudzilo, Corey J ^a   Szczesniak, Rhonda D ^b   Brody, Alan S ^b   Rattan, Mantosh S ^a   Krueger, Darcy A ^b   Bissler, John J ^b   Franz, David N ^b   McCormack, Francis X ^a   Young, Lisa R ^a,c  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMAGE PROCESSING; LUNG DISEASE; LYMPHANGIOLEIOMYOMATOSIS; MAJOR CLINICAL STUDY; MORTALITY; PATHOLOGICAL ANATOMY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SCREENING TEST; TUBEROUS SCLEROSIS;

EID: 84881329035     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2813     Document Type: Article

References (29)

1. Costello LC, Hartman TE, Ryu JH. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc. 2000; 75 (6): 591-594.
2. Moss J, Avila NA, Barnes PM, et al. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med. 2001; 164 (4): 669-671.
3. Franz DN, Brody A, Meyer C, et al. Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med. 2001; 164 (4): 661-668.
4. Muzykewicz DA, Sharma A, Muse V, Numis AL, Rajagopal J, Thiele EA. TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex. J Med Genet. 2009; 46 (7): 465-468.
5. Adriaensen ME, Schaefer-Prokop CM, Duyndam DA, Zonnenberg BA, Prokop M. Radiological evidence of lymphangioleiomyomatosis in female and male patients with tuberous sclerosis complex. Clin Radiol. 2011; 66 (7): 625-628.
6. Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A. 2000; 97 (11): 6085-6090.
7. Johnson SR, Cordier JF, Lazor R, et al; Review Panel of the ERS LAM Task Force. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J. 2010; 35 (1): 14-26.
8. Ryu JH, Hartman TE, Torres VE, Decker PA. Frequency of undiagnosed cystic lung disease in patients with sporadic renal angiomyolipomas. Chest. 2012; 141 (1): 163-168.
9. Moss M, Wellman DA, Cotsonis GA. An appraisal of multivariable logistic models in the pulmonary and critical care literature. Chest. 2003; 123 (3): 923-928.
10. Hosmer DW, Lemeshow S. Applied Logstic Regression. New York, NY: Wiley; 2000.
11. Seibert D, Hong CH, Takeuchi F, et al. Recognition of tuberous sclerosis in adult women: delayed presentation with lifethreatening consequences. Ann Intern Med. 2011 ;154(12): 806-813, W-294.
12. Franz DN, Bissler JJ, McCormack FX. Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics. 2010; 41 (5): 199-208.
13. McCormack FX. Lymphangioleiomyomatosis: a clinical update. Chest. 2008; 133 (2): 507-516.
14. Seaman DM, Meyer CA, Gilman MD, McCormack FX. Diffuse cystic lung disease at high-resolution CT. AJR Am J Roentgenol. 2011; 196 (6): 1305-1311.
15. Henske EP, McCormack FX. Lymphangioleiomyomatosis-a wolf in sheep's clothing. J Clin Invest. 2012; 122(11): 3807-3816.
16. Karbowniczek M, Astrinidis A, Balsara BR, et al. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med. 2003; 167 (7): 976-982.
17. Hayashi T, Kumasaka T, Mitani K, et al. Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis: a clinicopathologic study of 10 patients. Am J Surg Pathol. 2011; 35 (12): 1776-1785.
18. McCormack FX, Inoue Y, Moss J, et al; National Institutes of Health Rare Lung Diseases Consortium; MILES Trial Group. Effi cacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med. 2011; 364 (17): 1595-1606.
19. Koyama S, Aoyama T, Oda N, Yamauchi-Kawaura C. Radiation dose evaluation in tomosynthesis and C-arm cone-beam CT examinations with an anthropomorphic phantom. Med Phys. 2010; 37 (8): 4298-4306.
20. International Commission on Radiological Protection. Volume 99: ICRP Publication 99 Low-Dose Extrapolation of Radiation Related Cancer Risk, 1st Edition. Amsterdam, The Netherlands: Elsevier Health Sciences; 2006.
21. Brenner DJ, Doll R, Goodhead DT, et al. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci U S A. 2003; 100(24): 13761-13766.
22. Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012; 380 (9840): 499-505.
23. Perisinakis K, Papadakis AE, Damilakis J. The effect of x-ray beam quality and geometry on radiation utilization effi ciency in multidetector CT imaging. Med Phys. 2009; 36(4): 1258-1266.
24. Katsura M, Matsuda I, Akahane M, et al. Model-based iterative reconstruction technique for radiation dose reduction in chest CT: comparison with the adaptive statistical iterative reconstruction technique. Eur Radiol. 2012; 22(8): 1613-1623.
25. Aberle DR, Adams AM, Berg CD, et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365 (5): 395-409.
26. Ryu JH, Sykes AM, Lee AS, Burger CD. Cystic lung disease is not uncommon in men with tuberous sclerosis complex. Respir Med. 2012; 106 (11): 1586-1590.
27. Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol. 1998; 13 (12): 624-628.
28. Young LR, Inoue Y, McCormack FX. Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis. N Engl J Med. 2008; 358 (2): 199-200.
29. Young LR, Vandyke R, Gulleman PM, et al. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest. 2010; 138 (3): 674-681.